Natural History Study of Patients With Neurofibromatosis Type 2 | MicrobiomeTrials← Back to trialsNCT00598351
Natural History Study of Patients With Neurofibromatosis Type 2
RecruitingOBSERVATIONAL
Trial Details
Enrollment target: 269 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Neurofibromatosis Type 1
Background:
Neurofibromatosis type 1 (NF1) is a genetic condition that causes tumors to grow along the nerves in the sk…
Washington D.C., United StatesEst. completion May 1, 2027
Neurofibromatosis Type 1
This study is designed to define a dosing regimen and assess the pharmacokinetics(PK) and safety of the granule formulat…
Akron, United StatesEst. completion Nov 30, 2027
Phase 1
Recruiting
Neurofibroma, PlexiformPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Promyelocytic, AcuteSarcoma
Background:
\- Some people with cancer have solid tumors. Others have refractory leukemia. This may not go away after t…
Bethesda, United StatesEst. completion Dec 31, 2026